TY  - JOUR
AU  - Lizak, Nathaniel
AU  - Lugaresi, Alessandra
AU  - Alroughani, Raed
AU  - Lechner-Scott, Jeannette
AU  - Slee, Mark
AU  - Havrdova, Eva
AU  - Horakova, Dana
AU  - Trojano, Maria
AU  - Izquierdo, Guillermo
AU  - Duquette, Pierre
AU  - Girard, Marc
AU  - Prat, Alexandre
AU  - Grammond, Pierre
AU  - Hupperts, Raymond
AU  - Grand'Maison, Francois
AU  - Sola, Patrizia
AU  - Pucci, Eugenio
AU  - Bergamaschi, Roberto
AU  - Oreja-Guevara, Celia
AU  - Van Pesch, Vincent
AU  - Ramo, Cristina
AU  - Spitaleri, Daniele
AU  - Iuliano, Gerardo
AU  - Boz, Cavit
AU  - Granella, Franco
AU  - Olascoaga, Javier
AU  - Verheul, Freek
AU  - Rozsa, Csilla
AU  - Cristiano, Edgardo
AU  - Flechter, Shlomo
AU  - Hodgkinson, Suzanne
AU  - Amato, Maria Pia
AU  - Deri, Norma
AU  - Jokubaitis, Vilija
AU  - Spelman, Tim
AU  - Butzkueven, Helmut
AU  - Kalincik, Tomas
AU  - MSBase Study Group
PY  - 2016
DO  - 10.1136/jnnp-2016-313976
UR  - http://hdl.handle.net/10668/10485
T2  - Journal of neurology, neurosurgery, and psychiatry
AB  - To evaluate variability and predictability of disability trajectories in moderately advanced and advanced multiple sclerosis (MS), and their modifiability with immunomodulatory therapy. The epochs between Expanded Disability Status Scale (EDSS) steps...
LA  - en
KW  - Cohort Studies
KW  - Disability Evaluation
KW  - Disabled Persons
KW  - Disease Progression
KW  - Female
KW  - Humans
KW  - Immunomodulation
KW  - Male
KW  - Multiple Sclerosis, Relapsing-Remitting
TI  - Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.
TY  - research article
VL  - 88
ER  -